Search

everythinglearnresearchcommunity

for

Search:↓

Active treatment can help prevent scarring hair loss in SLE patients.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Skin symptoms in lupus help diagnose and manage the disease early.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Managing multiple autoimmune diseases in one patient is very challenging.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Systemic lupus erythematosus is a complex autoimmune disease mainly affecting women, with varied symptoms and unknown exact cause.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

Discoid Lupus Erythematosus is more common in women aged 31-40, often worsened by sunlight, and confirmed by specific lab tests.

Neonatal lupus symptoms usually resolve, but some children may develop other autoimmune diseases later.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.